Pharmaceutical & Biotech SWMS
Australian biopharmaceutical manufacturing operates under the PIC/S Guide to Good Manufacturing Practice for Medicinal Products (TGA-aligned) and the AS 1386 cleanroom classification framework. The two highest-frequency SWMS-needing activities are bioreactor cleaning between batches and cleanroom sterile compounding. Bioreactor cleaning combines a Clean-in-Place (CIP) cycle with periodic manual residue removal that requires confined-space entry into the vessel under AS 2865. Atmospheric testing and biological exposure controls are mandatory; residual product, live cell line, and CIP chemistry exposure are the primary hazards. The vessel must be closed out for sterilisation before reuse. Sterile compounding in ISO Class 5 / 7 cleanrooms covers gowning and airlock entry, biological safety cabinet or isolator work, parenteral fill-finish operations, and post-compounding decontamination. Single-pass airflow integrity and environmental monitoring are the critical-process steps.
2 SWMS in this category
2 ready-to-buy editable DOCXs · 8 state variants per product · delivered within 24 hours of payment.
🧪Bioreactor Cleaning SWMS
Biopharmaceutical bioreactor cleaning between batches — CIP cycle execution, manual rinse and inspect, vessel confined-space entry where man…
🧪Cleanroom Sterile Compounding SWMS
Sterile compounding in ISO Class 5 / 7 cleanroom — gowning and airlock entry, biological safety cabinet / isolator work, parenteral fill-fin…
Need a pharmaceutical SWMS?
AS 1386 + AS 2865 + PIC/S Guide to GMP referenced, editable DOCX, 8 state variants, instant download.
View all Pharmaceutical SWMS →